GlaxoSmithKline Inc recalls Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV
Recalled July 18, 2012 · FDA recall D-1412-2012 · GlaxoSmithKline
Hazard
Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets. · FDA Class II
Units
14,465 bottles
Sold at
Nationwide
Description
Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.
Product
Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18
Manufacturer(s)
GlaxoSmithKline Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →